Quarterly Financial Results for Period Ending June 30, 2026 - This 10-Q contains Amphenol's unaudited financial statements and results for the second quarter of 2026, including consolidated balance sheets, income statements, and cash flow statements comparing Q2 2026 to prior periods. Debt Instruments and Capital Structure - The filing discloses multiple debt instruments including delayed draw…

Our analysis rates this filing NEUTRAL. Amphenol presents a balanced risk profile appropriate for a diversified, investment-grade multinational manufacturer. The two identified risks—refinancing obligations and currency exposure—are material but manageable for a company of this scale and financial…

Concern level: ELEVATED (5.2/10). Key factors: High-severity refinancing risk: $1.534 billion in delayed draw term loans with 364-day maturities create near-term liquidity management obligations across multiple tranches (August 2025, November 2025, May 2026); Material foreign currency exposure: €500 million senior notes due October 2028 introduce EUR/USD exchange rate volatility affecting…

Notable risk changes: Significant near-term debt refinancing requirement: $1.534 billion in delayed draw term loans maturing within 12 months (364-day terms from August 2025, November 2025, and May 2026) creates liquidity management challenge; Material foreign currency exposure: €500 million senior notes due October 2028 introduces EUR/USD exchange rate risk to consolidated financial statements and debt service…

The model predicts APH will outperform the S&P 500 by about 0.0% over 30 days. This is model analysis for research, not investment advice.